Mutating coronavirus: what it means for all of us: Of course, disease outcomes are affected by other factors, too, such as how old or sick the host is. The effect of interventions also has to be considered. Until a large dataset of genome data from mild or non-symptomatic patients from a diverse population is available, it will be difficult to deduce how the convergent mutations identified translate to severity of disease.

Viewpoint: It’s better to admit ‘I don’t know’ than to speculate during a pandemic: COVID-19 has elevated, but also exposed scientists. Politicians want clarity, but it’s crucial to explain what is known, unknown and unknowable

How remdesivir works, and why it's not the ultimate coronavirus killer: The antiviral drug remdesivir has been approved for emergency use among hospitalized COVID-19 patients, and in recent studies, has shown promise as a treatment for the pandemic disease.

How exactly does remdesivir counter SARS-CoV-2 -- the coronavirus strain responsible for COVID-19?

How Epidemics End: Contrary to hopes for a tidy conclusion to the COVID-19 pandemic, history shows that outbreaks of infectious disease often have much murkier outcomes—including simply being forgotten about, or dismissed as someone else’s problem.

In the coronavirus pandemic, we're making decisions without reliable data

Coronavirus: scientists uncover why some people lose their sense of smell

Mounting clues suggest the coronavirus might trigger diabetes: Evidence from tissue studies and some people with COVID-19 shows that the virus damages insulin-producing cells.